KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · IEX Real-Time Price · USD
11.82
-0.25 (-2.07%)
At close: Jun 17, 2024, 4:00 PM
12.04
+0.22 (1.86%)
Pre-market: Jun 18, 2024, 7:10 AM EDT
KalVista Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for KALV stock have an average target of 25, with a low estimate of 20 and a high estimate of 35. The average target predicts an increase of 111.51% from the current stock price of 11.82.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 3, 2024.
Analyst Ratings
The average analyst rating for KALV stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $24 → $20 | Strong Buy | Maintains | $24 → $20 | +69.20% | May 3, 2024 |
| Needham | Needham | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +196.11% | May 1, 2024 |
| Needham | Needham | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +196.11% | Apr 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +103.05% | Mar 12, 2024 |
| Needham | Needham | Strong Buy Maintains $35 | Strong Buy | Maintains | $35 | +196.11% | Mar 11, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
16.41M
EPS This Year
-3.12
from -3.33
EPS Next Year
-2.61
from -3.12
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | 37.3M | 225.7M | 237.8M | 308.4M | 390.6M |
| Avg | n/a | 16.4M | 120.7M | 153.8M | 227.6M | 314.2M |
| Low | n/a | 5.6M | 50.7M | 85.4M | 125.3M | 184.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 1,275.8% | 97.1% | 100.6% | 71.6% |
| Avg | - | - | 635.6% | 27.4% | 48.0% | 38.1% |
| Low | - | - | 208.8% | -29.3% | -18.5% | -18.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.98 | -1.80 | 1.09 | 1.25 | 2.22 | 4.16 |
| Avg | -3.12 | -2.61 | -0.51 | -0.05 | 1.12 | 2.46 |
| Low | -3.16 | -3.24 | -1.64 | -1.21 | -0.63 | 0.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | - | 272.9% |
| Avg | - | - | - | - | - | 120.7% |
| Low | - | - | - | - | - | -79.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.